Conference Coverage
Latest News
Nov 17, 2025 | News
AEON's ABP-450 Achieves Critical Analytical Milestone, Demonstrating High Biosimilarity to BOTOX
Immune Signatures Outperform Clinical Appearance in Treatment Guidance
Nov 17, 2025
Q&A: How Clinicians Are Healing “Overdosed” Skin Damaged by Viral Trends
Nov 17, 2025
Roflumilast sNDA Accepted for Plaque Psoriasis in Patients 2 to 5 Years
Nov 17, 2025
Beyond Antibiotics: How Oral Denifanstat Could Reshape the Acne Pipeline
Nov 17, 2025
Advertisement
Shorts
1:30
Derm Dispatch: Live at SDPA Fall 2025
7 hours ago
by
Renata Block, DMSc, MMS, PA-C
0:13
Breast Cancer Care by Dermatologists: A Year-Round Commitment
14 days ago
by
Christopher G. Bunick, MD, PhD
0:34
Leave the Ladder Down: Mentoring the Next Generation
14 days ago
by
Lauren Miller, PA-C(+1 more)
0:30
Why Breast Cancer Patients Must Get Routine Skin Exams
17 days ago
by
Christopher G. Bunick, MD, PhD
1:00
New Oral Treatments to Revolutionize Psoriasis Care
18 days ago
by
Ronald Vender, MD, FRCPC
0:53
From Consultation to Transformation: Emphasizing Strategic Aesthetics at PDPA 2025
a month ago
by
Kachiu C. Lee, M.D.
0:42
Supporting Skin Health in the Prejuvenation Era
a month ago
by
Amy B. Lewis, MD
0:30
What Makes APG777 a Potential First-line Therapy?
a month ago
by
Emma Guttman-Yassky, MD, PhD
0:59
Treating Dermatological Diseases As Processes
a month ago
by
Brian Kim, MD
0:31
Fighting Misinformation on Injectables and HA Fillers
2 months ago
by
Lisa Espinoza, MD
Podcasts
Dermatology Times Digital Edition
Denifanstat emerges as a groundbreaking oral therapy for acne, targeting sebum production and inflammation, promising safer, effective treatment options.
Experts discuss essential skin care strategies for sensitive skin, emphasizing evidence-based cleansing and moisturizing to restore the compromised skin barrier.
Experts discuss effective strategies for managing facial hyperpigmentation, emphasizing personalized treatment plans and the importance of sun protection.
Experts discuss icotrokinra's potential to revolutionize psoriasis treatment with oral therapies, emphasizing efficacy, safety, and patient-centered care at EADV 2025.
In a recent Dermatology Times custom video series, Zoe Diana Draelos, MD, and Cheri Frey, MD, discussed evidence-based cleansing and moisturizing practices for sensitive skin.
ORKA-001 by Oruka Therapeutics offers promising yearly dosing for psoriasis, showcasing extended efficacy and safety in early clinical trials.
Skin pain in atopic dermatitis significantly impacts quality of life, necessitating its recognition and treatment as a vital symptom for better patient outcomes.
Explore the latest FDA approvals in dermatology, including treatments for eczema and psoriasis, and gain insights on chronic spontaneous urticaria.
Christopher Bunick, MD, PhD, emphasizes how dermatologists can improve outcomes through vigilant skin exams and collaborative care with oncology teams.
Discover the latest advancements in CSU therapy, including Gil Yosipovitch's insights on barzolvolimab's promising results and its potential impact on patient care.
Continuing Medical Education
All News
Advertisement
Advertisement
Catch up on coverage from the final day of the 2025 Elevate-Derm Fall Conference.
At Elevate-Derm, Buchi Neita, PA-C, discussed treatment expectations for vitiligo, triple-combination cream for acne, early diagnosis in HS, and what she’s looking forward to in the 2026 pipeline.
At Elevate-Derm Fall, Patricia Delgado, DNP, AGPCNP, DCNP, PMHNP, outlined practical ways dermatology clinicians can incorporate psychodermatology principles and previewed the upcoming Psych and Skin video series.
Lisa Weiss, MMSc, PA-C, and Justin Love, PA-C, discuss the importance of broad differentials, repeat biopsies, and national networking to strengthen diagnostic accuracy and provider support at Elevate-Derm Fall.
Julio Gonzalez Paoli, MD, shares tips for early lupus diagnosis at the Elevate-Derm Fall Conference.
Catch up on coverage from the third day of the 2025 Elevate-Derm Fall Conference.
At Elevate-Derm Fall, Peter Lio, MD, discussed how flexible clinical reasoning and an expanding therapeutic pipeline, particularly hidradenitis suppurativa and atopic dermatitis, are reshaping patient management heading into 2026.
Diego Ruiz Dasilva, MD, shares his expert insights on vitiligo, including treatment options, future therapies, and the importance of combination therapy for effective management.
Hilary Baldwin, MD, shares tips for diagnosing rosacea in patients with darker skin tones.
At Elevate-Derm Fall, sisters Shanna Miranti, MPAS, PA-C, and Larissa Schmidt, DPM, reviewed the benefits of cross-specialty collaboration for patient care.
Advertisement
Michael Rosenblum’s team identified a previously underappreciated fibroblast subset that actively regulates inflammation, fibrosis, and microbial containment in the skin.
Therapeutic modulation of mitochondria offers a pathway to control multiple cytokine pathways simultaneously.
Catch up on coverage from the second day of the 2025 Elevate-Derm Fall Conference.
At the Elevate-Derm Fall Conference, Peter Lio, MD, highlighted practical strategies for corticosteroid stewardship, the expanding role of nonsteroidal topicals, and emerging opportunities in early-age indications that are reshaping pediatric inflammatory dermatoses care.
Baldwin discusses the latest advancements in acne and rosacea treatments, including innovative therapies and promising clinical trials.
Advertisement
Advertisement
Trending on Dermatology Times
1
Improving Outcomes in Acne, Hidradenitis Suppurativa, and Vitiligo Through Treatment Advancements
2
Roflumilast sNDA Accepted for Plaque Psoriasis in Patients 2 to 5 Years
3
Beyond Antibiotics: How Oral Denifanstat Could Reshape the Acne Pipeline
4
Immune Signatures Outperform Clinical Appearance in Treatment Guidance
5
